MORGENTHALER VENTURE PARTNERS IX LP
Insider CIK 1439101 · VAPO 10% owner · RARX 10% owner · CALA 10% owner · DOCS 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DOCS Doximity, Inc. | J Other | 2021-11-12 | 2021-11-12 | 8,535,175 | — | $0 | 8,535,175 | SEC↗ |
| DOCS Doximity, Inc. | C Conversion deriv | 2021-11-10 | 2021-11-12 | 17,070,350 | — | $0 | 0 | SEC↗ |
| DOCS Doximity, Inc. | C Conversion | 2021-11-10 | 2021-11-12 | 17,070,350 | — | $0 | 17,070,350 | SEC↗ |
| DOCS Doximity, Inc. | C Conversion deriv | 2021-06-28 | 2021-06-28 | 1,659,476 | — | $0 | 0 | SEC↗ |
| DOCS Doximity, Inc. | C Conversion deriv | 2021-06-28 | 2021-06-28 | 15,410,874 | — | $0 | 0 | SEC↗ |
| DOCS Doximity, Inc. | C Conversion deriv | 2021-06-28 | 2021-06-28 | 17,070,350 | — | $0 | 17,070,350 | SEC↗ |
| VAPO VAPOTHERM INC | C Conversion deriv | 2018-11-16 | 2018-11-20 | 359,842 | — | $0 | 0 | SEC↗ |
| VAPO VAPOTHERM INC | C Conversion deriv | 2018-11-16 | 2018-11-20 | 129,418 | — | $0 | 0 | SEC↗ |
| VAPO VAPOTHERM INC | C Conversion deriv | 2018-11-16 | 2018-11-20 | 61,342 | — | $0 | 0 | SEC↗ |
| VAPO VAPOTHERM INC | C Conversion deriv | 2018-11-16 | 2018-11-20 | 217,803 | — | $0 | 0 | SEC↗ |
| VAPO VAPOTHERM INC | C Conversion deriv | 2018-11-16 | 2018-11-20 | 214,285 | — | $0 | 0 | SEC↗ |
| VAPO VAPOTHERM INC | C Conversion | 2018-11-16 | 2018-11-20 | 61,342 | — | $0 | 982,690 | SEC↗ |
| VAPO VAPOTHERM INC | C Conversion | 2018-11-16 | 2018-11-20 | 921,348 | — | $0 | 921,348 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion deriv | 2016-10-31 | 2016-10-31 | 3,664,071 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion deriv | 2016-10-31 | 2016-10-31 | 9,744,916 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion deriv | 2016-10-31 | 2016-10-31 | 3,408,439 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | X Exercise deriv | 2016-10-31 | 2016-10-31 | 63,019 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | P Buy | 2016-10-31 | 2016-10-31 | 263,538 | $13.00 | $3.43M | 2,745,846 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | X Exercise | 2016-10-31 | 2016-10-31 | 63,019 | $0.07 | $4.4K | 80,161 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2016-10-31 | 2016-10-31 | 340 | $13.00 | $4.4K | 79,821 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion | 2016-10-31 | 2016-10-31 | 486,919 | — | $0 | 2,482,308 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion | 2016-10-31 | 2016-10-31 | 523,438 | — | $0 | 1,995,389 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | C Conversion | 2016-10-31 | 2016-10-31 | 1,392,130 | — | $0 | 1,471,951 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 634,195 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 747,540 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 419,181 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion deriv | 2014-10-07 | 2014-10-09 | 10,999 | — | $0 | 0 | SEC↗ |
| CALA Calithera Biosciences, Inc | C Conversion | 2014-10-07 | 2014-10-09 | 1,811,915 | $10.00 | $18.12M | 1,811,915 | SEC↗ |
| CALA Calithera Biosciences, Inc | P Buy | 2014-10-07 | 2014-10-09 | 350,000 | $10.00 | $3.50M | 2,161,915 | SEC↗ |